THE ENHANCED LIVER FIBROSIS TEST IS ASSOCIATED WITH DEVELOPMENT OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Trembling, Paul M. [1 ]
Grecian, Sheila M. [2 ]
Strachan, Mark W. J. [2 ]
Rosenberg, William M. [1 ]
Fallowfield, Jonathan A. [3 ]
机构：
[1] UCL, Inst Liver & Digest Hlth, Div Med, London, England
[2] Western Gen Hosp, Metab Unit, Edinburgh, Midlothian, Scotland
[3] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
来源：
GUT | 2023年 / 72卷 / SUPPL_3期
关键词：
D O I：
10.1136/gutjnl-2023-BASL.78
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P62
引用
收藏
页码：A54 / A54
页数：1
相关论文
共 50 条
  • [31] Enhanced Liver Fibrosis test and liver stiffness measurements identify high prevalence of advanced fibrosis in people with type 2 diabetes
    Patel, P. J.
    Stuart, K. A.
    Horsfall, L. U.
    Hayward, K. L.
    Hossain, F.
    Williams, S.
    Johnson, T.
    Brown, N.
    Lampe, G.
    Buck, L.
    Saad, N.
    Clouston, A.
    Irvine, K. M.
    Russell, A.
    Valery, P. C.
    Powell, E. E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 103 - 103
  • [32] Diabetes is not associated with increased risk of hepatocellular carcinoma in patients with hepatitis C and advanced fibrosis or cirrhosis
    Yang, Ju Dong
    Kim, Donghee
    Roberts, Lewis R.
    Kim, W. Ray
    HEPATOLOGY, 2013, 58 : 1218A - 1219A
  • [33] Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
    Qi, Yueying
    Fan, Lirong
    Ran, Decong
    Xu, Jieda
    Wang, Yuansong
    Wu, Jin
    Zhang, Zhongyong
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [34] Combined 'En Bloc' Liver and Pancreas Transplantation in Patient With Hepatocellular Carcinoma and Type 2 Diabetes Mellitus
    Ju, Weiqiang
    Guo, Zhiyong
    Lin, Jianwei
    Wang, Dongping
    He, Xiaoshun
    LIVER TRANSPLANTATION, 2014, 20 : S290 - S290
  • [35] Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
    Barb, Diana
    Repetto, Enrico M.
    Stokes, Michael E.
    Shankar, Sudha S.
    Cusi, Kenneth
    OBESITY, 2021, 29 (11) : 1950 - 1960
  • [36] Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma
    Taura, Naota
    Ichikawa, Tatsuki
    Miyaaki, Hisamitsu
    Yatsuhashi, Hiroshi
    Ishibashi, Hiromi
    Nakao, Kazuhiko
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (01) : 81 - 84
  • [37] INCREASED RISK OF HEPATOCELLULAR CARCINOMA AND THERAPY OF TYPE 2 DIABETES MELLITUS
    Perciaccante, A.
    Balbi, M.
    Casarin, P.
    Zanette, G.
    Donadon, V.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S296 - S296
  • [38] Is Type 2 Diabetes Mellitus a Predisposal Cause for Developing Hepatocellular Carcinoma?
    Mukherjee, Biswajit
    Bhattacharya, Sanchari
    Chakraborty, Samrat
    Satapathy, Bhabani Sankar
    Dey, Niladri Shekhar
    Shaw, Tapan Kumar
    CURRENT DIABETES REVIEWS, 2015, 11 (02) : 64 - 70
  • [39] Disappearance of diabetes mellitus during the development of cirrhosis of the liver
    Bordley, J
    BULLETIN OF THE JOHNS HOPKINS HOSPITAL, 1930, 47 : 113 - 122
  • [40] Enhanced Liver Fibrosis Score as a Predictor of Hepatocellular Carcinoma
    Loo, Wai Mun
    Goh, George Boon-Bee
    Wang, Yeli
    Yuan, Jian-Min
    Ong, Lizhen
    Dan, Yock Young
    Koh, Woon-Puay
    CLINICAL CHEMISTRY, 2018, 64 (09) : 1404 - 1405
12345